
Stella Kim Yi
Examiner (ID: 16227, Phone: (571)270-5123 , Office: P/1742 )
| Most Active Art Unit | 1742 |
| Art Unit(s) | 1791, 1742 |
| Total Applications | 1087 |
| Issued Applications | 708 |
| Pending Applications | 102 |
| Abandoned Applications | 311 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20059234
[patent_doc_number] => 20250197456
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-19
[patent_title] => NOVEL AAV CAPSIDS FOR TARGETING NERVOUS SYSTEM AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 19/026966
[patent_app_country] => US
[patent_app_date] => 2025-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10928
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19026966
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/026966 | NOVEL AAV CAPSIDS FOR TARGETING NERVOUS SYSTEM AND USES THEREOF | Jan 16, 2025 | Pending |
Array
(
[id] => 20092098
[patent_doc_number] => 20250222034
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-07-10
[patent_title] => MESENCHYMAL STROMAL CELL-DERIVED EXTRACELLULAR VESICLE-EXOSOMES
[patent_app_type] => utility
[patent_app_number] => 19/017125
[patent_app_country] => US
[patent_app_date] => 2025-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4926
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19017125
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/017125 | MESENCHYMAL STROMAL CELL-DERIVED EXTRACELLULAR VESICLE-EXOSOMES | Jan 9, 2025 | Pending |
Array
(
[id] => 19904330
[patent_doc_number] => 12281326
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2025-04-22
[patent_title] => Composition for regulating production of proteins
[patent_app_type] => utility
[patent_app_number] => 18/990401
[patent_app_country] => US
[patent_app_date] => 2024-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 144
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18990401
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/990401 | Composition for regulating production of proteins | Dec 19, 2024 | Issued |
Array
(
[id] => 19751957
[patent_doc_number] => 20250040522
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-06
[patent_title] => MUTANT MYOCILIN DISEASE MODEL AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/717225
[patent_app_country] => US
[patent_app_date] => 2022-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 70136
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -71
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18717225
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/717225 | MUTANT MYOCILIN DISEASE MODEL AND USES THEREOF | Dec 7, 2022 | Pending |
Array
(
[id] => 18351874
[patent_doc_number] => 20230139985
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => Self-Complementary Adeno-Associated Virus Vector and its Use in Treatment of Muscular Dystrophy
[patent_app_type] => utility
[patent_app_number] => 18/046740
[patent_app_country] => US
[patent_app_date] => 2022-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20177
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18046740
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/046740 | Self-complementary adeno-associated virus vector and its use in treatment of muscular dystrophy | Oct 13, 2022 | Issued |
Array
(
[id] => 18349232
[patent_doc_number] => 20230137343
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => METHODS AND COMPOSITIONS FOR ENHANCING ACTIVITY OF T CELLS WITH MODIFIED B CELLS
[patent_app_type] => utility
[patent_app_number] => 17/938545
[patent_app_country] => US
[patent_app_date] => 2022-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33090
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17938545
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/938545 | METHODS AND COMPOSITIONS FOR ENHANCING ACTIVITY OF T CELLS WITH MODIFIED B CELLS | Oct 5, 2022 | Pending |
Array
(
[id] => 18537820
[patent_doc_number] => 20230242922
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => GENE EDITING TOOLS
[patent_app_type] => utility
[patent_app_number] => 17/931858
[patent_app_country] => US
[patent_app_date] => 2022-09-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21075
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17931858
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/931858 | GENE EDITING TOOLS | Sep 12, 2022 | Pending |
Array
(
[id] => 18242823
[patent_doc_number] => 20230075134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => METHOD FOR ISOLATING AND PURIFYING MESENCHYMAL STEM CELLS FROM HERNIA SAC AND METHOD FOR TISSUE REPAIR BY USING MESENCHYMAL STEM CELLS FROM HERNIA SAC
[patent_app_type] => utility
[patent_app_number] => 17/895418
[patent_app_country] => US
[patent_app_date] => 2022-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4027
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 154
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17895418
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/895418 | METHOD FOR ISOLATING AND PURIFYING MESENCHYMAL STEM CELLS FROM HERNIA SAC AND METHOD FOR TISSUE REPAIR BY USING MESENCHYMAL STEM CELLS FROM HERNIA SAC | Aug 24, 2022 | Abandoned |
Array
(
[id] => 18194016
[patent_doc_number] => 20230047535
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => INDUCTION OF NEUROGENESIS USING UMBILICAL CORD DERIVED MESENCHYMAL STEM CELLS AND DERIVATIVES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/886407
[patent_app_country] => US
[patent_app_date] => 2022-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2340
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17886407
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/886407 | INDUCTION OF NEUROGENESIS USING UMBILICAL CORD DERIVED MESENCHYMAL STEM CELLS AND DERIVATIVES THEREOF | Aug 10, 2022 | Abandoned |
Array
(
[id] => 18192787
[patent_doc_number] => 20230046306
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => USE OF MESENCHYMAL STEM CELLS AND COMPOSITIONS CONTAINING THEM IN THE MANUFACTURE OF A MEDICAMENT FOR TREATING HARD-TO-HEAL BURN WOUNDS
[patent_app_type] => utility
[patent_app_number] => 17/819052
[patent_app_country] => US
[patent_app_date] => 2022-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5102
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17819052
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/819052 | USE OF MESENCHYMAL STEM CELLS AND COMPOSITIONS CONTAINING THEM IN THE MANUFACTURE OF A MEDICAMENT FOR TREATING HARD-TO-HEAL BURN WOUNDS | Aug 10, 2022 | Abandoned |
Array
(
[id] => 17988861
[patent_doc_number] => 20220354898
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => INDUCTION OF TUMOR VASCULAR NECROSIS UTILIZING FIBROBLASTS
[patent_app_type] => utility
[patent_app_number] => 17/738584
[patent_app_country] => US
[patent_app_date] => 2022-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21304
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -32
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17738584
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/738584 | INDUCTION OF TUMOR VASCULAR NECROSIS UTILIZING FIBROBLASTS | May 5, 2022 | Pending |
Array
(
[id] => 17761711
[patent_doc_number] => 20220235323
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-07-28
[patent_title] => Use of a Warmer For Promoting a Biological Reaction
[patent_app_type] => utility
[patent_app_number] => 17/702592
[patent_app_country] => US
[patent_app_date] => 2022-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5060
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17702592
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/702592 | Use of a Warmer For Promoting a Biological Reaction | Mar 22, 2022 | Pending |
Array
(
[id] => 18988117
[patent_doc_number] => 20240060086
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-22
[patent_title] => LIGHT-CONTROLLED VIRAL TRANSDUCTION
[patent_app_type] => utility
[patent_app_number] => 18/037945
[patent_app_country] => US
[patent_app_date] => 2021-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25583
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 146
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18037945
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/037945 | LIGHT-CONTROLLED VIRAL TRANSDUCTION | Nov 21, 2021 | Pending |
Array
(
[id] => 20171427
[patent_doc_number] => 12390146
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-19
[patent_title] => Reagents and methods for modulating cone photoreceptor activity
[patent_app_type] => utility
[patent_app_number] => 17/500426
[patent_app_country] => US
[patent_app_date] => 2021-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 9915
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17500426
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/500426 | Reagents and methods for modulating cone photoreceptor activity | Oct 12, 2021 | Issued |
Array
(
[id] => 18184031
[patent_doc_number] => 20230044761
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => MATERIALS AND METHODS FOR ENGINEERING CELLS AND USES THEREOF IN IMMUNO-ONCOLOGY
[patent_app_type] => utility
[patent_app_number] => 17/491757
[patent_app_country] => US
[patent_app_date] => 2021-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 87420
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17491757
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/491757 | MATERIALS AND METHODS FOR ENGINEERING CELLS AND USES THEREOF IN IMMUNO-ONCOLOGY | Sep 30, 2021 | Abandoned |
Array
(
[id] => 18184031
[patent_doc_number] => 20230044761
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-09
[patent_title] => MATERIALS AND METHODS FOR ENGINEERING CELLS AND USES THEREOF IN IMMUNO-ONCOLOGY
[patent_app_type] => utility
[patent_app_number] => 17/491757
[patent_app_country] => US
[patent_app_date] => 2021-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 87420
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17491757
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/491757 | MATERIALS AND METHODS FOR ENGINEERING CELLS AND USES THEREOF IN IMMUNO-ONCOLOGY | Sep 30, 2021 | Abandoned |
Array
(
[id] => 19020519
[patent_doc_number] => 20240076690
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-07
[patent_title] => VIRAL VECTORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/028029
[patent_app_country] => US
[patent_app_date] => 2021-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6333
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18028029
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/028029 | VIRAL VECTORS AND USES THEREOF | Sep 28, 2021 | Pending |
Array
(
[id] => 20227365
[patent_doc_number] => 12416008
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-16
[patent_title] => Compositions and methods of use for small-molecule regulation of CRISPR-Cas9 activity using RNA aptamers
[patent_app_type] => utility
[patent_app_number] => 17/375808
[patent_app_country] => US
[patent_app_date] => 2021-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 21
[patent_no_of_words] => 8687
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17375808
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/375808 | Compositions and methods of use for small-molecule regulation of CRISPR-Cas9 activity using RNA aptamers | Jul 13, 2021 | Issued |
Array
(
[id] => 18549984
[patent_doc_number] => 20230247982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-10
[patent_title] => Improving Packed Red Blood Cell Storage with a High Viscosity Buffered Storage Solution
[patent_app_type] => utility
[patent_app_number] => 18/015158
[patent_app_country] => US
[patent_app_date] => 2021-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5914
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18015158
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/015158 | Improving Packed Red Blood Cell Storage with a High Viscosity Buffered Storage Solution | Jul 12, 2021 | Pending |
Array
(
[id] => 17440774
[patent_doc_number] => 20220061279
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => GENETICALLY MODIFIED CELLS, TISSUES, AND ORGANS FOR TREATING DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/365643
[patent_app_country] => US
[patent_app_date] => 2021-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 62448
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17365643
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/365643 | GENETICALLY MODIFIED CELLS, TISSUES, AND ORGANS FOR TREATING DISEASE | Jun 30, 2021 | Pending |